F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Short Interest Update

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the recipient of a large increase in short interest in July. As of July 15th, there was short interest totaling 22,041 shares, an increase of 115.9% from the June 30th total of 10,208 shares. Based on an average daily volume of 9,029 shares, the days-to-cover ratio is presently 2.4 days. Currently, 0.8% of the shares of the stock are sold short.

Institutional Trading of F/m Emerald Life Sciences Innovation ETF

An institutional investor recently raised its position in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC boosted its position in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 8.3% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 49,739 shares of the company’s stock after acquiring an additional 3,831 shares during the period. Hunter Associates Investment Management LLC owned about 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 at the end of the most recent reporting period.

F/m Emerald Life Sciences Innovation ETF Price Performance

NASDAQ:LFSC traded down $0.47 on Wednesday, reaching $44.93. The stock had a trading volume of 2,848 shares, compared to its average volume of 4,750. F/m Emerald Life Sciences Innovation ETF has a 12-month low of $24.22 and a 12-month high of $47.68. The firm’s fifty day moving average is $42.50 and its two-hundred day moving average is $38.35.

About F/m Emerald Life Sciences Innovation ETF

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.